Dragon Pharma PT-141
PT-141 10mg represents a cutting-edge advancement in peptide-based sexual health supplementation, containing the powerful melanocortin receptor agonist Bremelanotide. This innovative 10mg vial formulation offers bodybuilders, fitness enthusiasts, and individuals seeking enhanced sexual function a scientifically-backed solution that operates through a completely different mechanism than traditional PDE5 inhibitors like Viagra or Cialis. As part of Dragon Pharma's specialized peptide portfolio, this product delivers laboratory-grade Bremelanotide in lyophilized powder form, ensuring maximum stability and precise dosing for both male and female users.
PT-141 (Bremelanotide) functions primarily through activation of melanocortin receptors in the central nervous system, particularly MC4R, which plays a crucial role in sexual arousal pathways. Unlike vasodilatory medications that address physiological aspects of erectile function, PT-141 works at the neurological level to enhance sexual desire and arousal. This makes it particularly valuable for individuals experiencing decreased libido due to hormonal fluctuations, aging, or the psychological demands of intense training regimens. For bodybuilders and athletes, this can be especially relevant during cutting phases or when using compounds that may affect sexual function.
The 10mg concentration in Dragon Pharma's formulation provides optimal flexibility for both new users and experienced peptide enthusiasts. Each vial contains sufficient Bremelanotide for multiple doses, allowing for precise titration based on individual response and requirements. The lyophilized powder presentation in a sterile 2mL vial ensures pharmaceutical-grade purity and facilitates accurate reconstitution with bacteriostatic water. This presentation method maintains peptide integrity until administration, a critical factor given the sensitivity of melanocortin peptides to degradation.
Beyond its primary applications, PT-141 represents an interesting component of comprehensive wellness and performance protocols. Its mechanism of action suggests potential benefits for mood regulation and stress response, though its primary validated use remains focused on sexual function enhancement. Dragon Pharma's commitment to quality is evident in every aspect of this product's production, from raw material sourcing to final packaging. The 10mg strength represents a balanced option that accommodates various dosing strategies while providing excellent value through multiple doses per vial.
Key Benefits:
- Neurological Libido Enhancement: Works centrally in the brain to stimulate sexual arousal pathways, not just peripheral blood flow
- Dual-Gender Efficacy: Clinically studied and effective for both men and women experiencing sexual dysfunction
- Non-Hormonal Mechanism: Does not interfere with natural hormone production or require PCT like anabolic compounds
- Rapid Onset of Action: Noticeable effects typically within 2-4 hours, with peak activity at 4-6 hours post-administration
- No Dependency Development: Does not create physiological dependence or tolerance with responsible cycling
Each 2mL vial contains 10mg of Bremelanotide (PT-141) lyophilized powder, manufactured under strict pharmaceutical standards in Dragon Pharma's certified European facilities with rigorous quality control procedures ensuring purity, potency, and sterility.
Product Specifications
| Product Name |
PT-141 10 mg |
| Manufacturer |
Dragon Pharma |
| Substance |
Bremelanotide (Melanocortin Receptor Agonist) |
| Packaging |
2 mL Glass Vial with Lyophilized Powder |
| Lab Test Result |
Third-party verification available upon request |
| Half-Life |
Approximately 2-3 hours (effects persist 6-12 hours) |
| Recommended Cycle |
As needed, typically 1-3 times weekly maximum |
| Form |
Lyophilized Powder for Subcutaneous Injection |
| Aromatization |
No (non-steroidal peptide) |
| Dosage (Men) |
1.0-1.75mg as needed, 2-4 hours before anticipated activity |
Usage Guidelines
PT-141 administration requires careful attention to dosage and timing for optimal results with minimal side effects. Reconstitute the 10mg vial with 2mL of bacteriostatic water to create a concentration of 5mg/mL. For more precise dosing, consider using 1mL for 10mg/mL concentration. Use insulin syringes for accurate measurement, with each 10-unit mark on a 100-unit syringe representing 0.5mg when reconstituted with 2mL. Administer subcutaneously in abdominal fat tissue, rotating injection sites to prevent irritation.
PT-141 can be incorporated into comprehensive sexual health and performance protocols alongside other Dragon Pharma products. For those addressing multiple aspects of sexual function, consider combining with Cialis for complementary mechanisms of action. Users on testosterone replacement therapy might benefit from adding Proviron for enhanced free testosterone levels and libido synergy. Those experiencing performance anxiety may find Selank helpful for its anxiolytic properties.
- Beginner Protocol: Start with 0.5mg dose to assess tolerance. If well-tolerated, increase to 1.0mg for subsequent uses. Administer 2-4 hours before anticipated sexual activity. Limit to once weekly initially to monitor response and side effects.
- Intermediate Protocol: 1.0-1.5mg dose 2-4 hours before activity. Can be used 1-2 times weekly with at least 3 days between doses. Consider stacking with Viagra for combined neurological and vasodilation effects if appropriate.
- Advanced Protocol: 1.5-1.75mg dose (never exceed 2.0mg) 2-4 hours before activity. Maximum frequency 2-3 times weekly with proper spacing. Advanced users may incorporate Testo Blend 350 for comprehensive hormonal optimization.
Post Cycle Therapy (PCT):
PT-141 does not suppress natural hormone production, so traditional PCT is unnecessary. However, users should implement a "drug holiday" approach, taking 2-4 weeks off after 8-12 weeks of regular use to prevent potential receptor desensitization. During breaks, focus on natural libido enhancers and lifestyle optimization. For those using PT-141 alongside suppressive compounds, implement standard PCT protocols for those substances, such as Clomid or Nolvadex as appropriate.
Liver Protection:
PT-141 is not hepatotoxic and undergoes minimal liver metabolism. However, users combining it with oral anabolic compounds should implement standard liver protection protocols. Consider incorporating TUDCA at 500mg daily or NAC at 600-1200mg daily when using hepatotoxic substances. Regular monitoring of liver enzymes remains important during any extended supplementation protocol involving multiple compounds.
Storage Instructions
Proper storage is essential for maintaining PT-141 potency and stability. Store unopened vials in their original packaging at 2-8°C (36-46°F) – refrigerated but not frozen. The lyophilized powder form offers superior stability compared to pre-reconstituted solutions, with a shelf life of up to 24 months when properly stored. Avoid temperature fluctuations by placing vials in the main refrigerator compartment rather than the door where temperatures fluctuate more.
Once reconstituted with bacteriostatic water, the solution maintains optimal potency for 20-30 days when refrigerated. Clearly mark the reconstitution date on the vial. Never use beyond 30 days due to potential bacterial contamination and peptide degradation. Protect from light exposure by storing vials in their original packaging or opaque containers. For travel, use insulated medical cooler bags with temperature-stable gel packs to maintain the recommended temperature range during transport.
What is PT-141 peptide used for?
PT-141 (Bremelanotide) is primarily used to enhance sexual function in both men and women. It works by activating melanocortin receptors in the central nervous system, particularly MC4R, to stimulate sexual arousal pathways. Unlike traditional erectile dysfunction medications that increase blood flow, PT-141 enhances libido and desire at the neurological level. It's particularly useful for individuals experiencing decreased sexual interest due to hormonal changes, stress, or the effects of certain medications or training regimens.
How long does it take for PT-141 to kick in?
PT-141 typically begins working within 2-4 hours after subcutaneous administration, with peak effects occurring around 4-6 hours post-injection. The onset time can vary based on individual metabolism, dosage, and whether taken with food (fasting may accelerate absorption). Effects generally last 6-12 hours, though some users report residual effects up to 24 hours. It's recommended to administer PT-141 approximately 2-4 hours before anticipated sexual activity for optimal timing of effects.
Is PT-141 better than Viagra?
PT-141 and Viagra work through completely different mechanisms and are not directly comparable. Viagra (sildenafil) is a PDE5 inhibitor that increases blood flow to the genital area, addressing the physiological aspect of erectile function. PT-141 works centrally in the brain to enhance sexual desire and arousal. For individuals with both arousal and erectile issues, they may be used complementarily. PT-141 is particularly advantageous for those with decreased libido rather than purely physiological erectile dysfunction, and it works for both men and women, unlike Viagra which is primarily for men.
What are the most common side effects of PT-141?
The most common side effects include transient nausea (especially with higher initial doses), facial flushing, and mild headache. These typically subside within 1-2 hours. Less common effects include increased blood pressure, appetite suppression, and yawning. Side effects are generally dose-dependent and diminish with continued use as the body adapts. Starting with a low dose (0.5-1.0mg) and gradually increasing allows most users to minimize side effects while achieving desired benefits.
Can women use PT-141, and what dosage is appropriate?
Yes, PT-141 is effective for women and has been clinically studied for female sexual dysfunction. The typical starting dose for women is 0.5-0.75mg, which can be increased gradually to 1.0-1.25mg based on tolerance and response. Women generally require slightly lower doses than men for equivalent effects. Administration timing is similar—2-4 hours before anticipated sexual activity. Female users should start at the lower end of the dosage range and increase gradually while monitoring for side effects, particularly nausea which appears to be more common in women at equivalent doses.
